Compare Apple Inc (AAPL) vs ACADIA Pharmaceuticals Inc. (ACAD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Apple Inc vs ACADIA Pharmaceuticals Inc. — how do they compare? Apple Inc trades at $312.84 (market cap $4.56T), while ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B). The key difference: Apple Inc is far larger — about 1015.6× ACADIA Pharmaceuticals Inc.'s market cap, and Apple Inc pays a 0.35% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| AAPL | ACAD | |
|---|---|---|
Market Cap | $4.56T | $4.49B |
Volume | 100,358,844 | — |
Sector | Technology | Health |
52-Week High | $315.20 | $28.06 |
52-Week Low | $202.38 | $20.06 |
Enterprise Value | $4.58T | $3.69B |
Dividend Yield | 0.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AAPL trades at $310.66, down 0.64% on the day, with a bullish technical outlook supported by moving averages and strong fundamentals including a 26.91% net margin and consistent earnings beats. Revenue grew to $416.16B in 2025, and analyst consensus is a Buy with a $329.62 price target. Recent news highlights AI potential via 2.5B active devices and Gemini partnership, though store closures and union disputes pose headwinds.
The stock offers upside to consensus targets with robust cash flow and profitability, but high valuations (P/E 37.61) and competitive pressures warrant caution. Near-term focus is on Q2 2026 earnings against a $1.88 EPS expectation, with institutional activity mixed amid broader market rotation concerns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →
